Meeting
2018 ASCO Annual Meeting
Incidence of PI3K pathway aberrations and their impact on response to neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC) subtypes.
Authors
Reva K Basho
Cedars-Sinai Medical Center, Los Angeles, CA
Reva K Basho , Alex Trevarton , Kenneth R. Hess , Chunxiao Fu , Rosanna Lau , Chih-Hsu Lin , Olivier Lichtarge , Wei Tse Yang , William Fraser Symmans , Stacy L. Moulder
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Neoadjuvant Therapy
Citation
J Clin Oncol 36, 2018 (suppl; abstr 588)
DOI
10.1200/JCO.2018.36.15_suppl.588
Abstract #
588
Poster Bd #
80
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2016 ASCO Annual Meeting
Somatic alterations in the PTEN-PI3K-AKT-mTOR pathway in a cohort of 379 ovarian cancer patients.
First Author: Elizabeth Stover
Poster
2017 ASCO Annual Meeting
Pathogenic variants in DNA damage response (DDR) genes in patients with advanced solid tumors.
First Author: Ecaterina Elena Ileana Dumbrava
Poster
2015 ASCO Annual Meeting
Genomic profiling of large-cell neuroendocrine carcinoma of the lung.
First Author: Tomohiro Miyoshi
Poster
2020 ASCO Virtual Scientific Program
Genomic landscape and immune phenotype of malignant pleural mesothelioma.
First Author: Meera Patel